CM – Trillium Therapeutics shares up 192% after Pfizer acquires $ 2.3 billion

0

Keywords:

Pfizer,Trillium Therapeutics Inc.,NASDAQ:TRIL,Nasdaq,Stock,Oncology,Pfizer, Trillium Therapeutics Inc., NASDAQ:TRIL, Nasdaq, Stock, Oncology,,,,acquisition,blood cancer,breakthrough,Canada,conference,financial advisor,hematology,immune response,immunotherapy,leadership,lung cancer,participants,Pfizer,shareholders,therapeutics,United States,,Business, Finance, & Economics,,

Donnez votre avis et abonnez-vous pour plus d’infos

Vidéo du jour: